| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/08/2007 | EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists |
| 08/08/2007 | EP1815860A2 Phosphate transport inhibitors |
| 08/08/2007 | EP1814878A1 Spiro-2, 4-pyrimidinediamine compounds and their uses |
| 08/08/2007 | EP1814877A2 Diphenyl substituted alkanes as flap inhibitors |
| 08/08/2007 | EP1814866A2 Gonadotropin releasing hormone receptor antagonists |
| 08/08/2007 | EP1814863A1 Indazole sulphonamide derivatives |
| 08/08/2007 | EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 08/08/2007 | EP1814550A2 N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| 08/08/2007 | EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/08/2007 | EP1631285B1 Therapeutic agents useful for treating pain |
| 08/08/2007 | EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors |
| 08/08/2007 | EP1554264B1 Medicinal arylethanolamine compounds |
| 08/08/2007 | EP1532142A4 Polypeptide cleavage process |
| 08/08/2007 | EP1467992B1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
| 08/08/2007 | EP1432705B1 Dual action antibiotics |
| 08/08/2007 | EP0927180B1 Heterocyclic compounds and their use for isolating nucleic acids |
| 08/08/2007 | CN1330647C Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/08/2007 | CN101014714A Method for the production of diarylcycloalkyl derivatives |
| 08/08/2007 | CN101014612A Compounds for proteasome enzyme inhibition |
| 08/08/2007 | CN101014594A 哌啶衍生物作为肾素抑制剂 Piperidine derivatives as renin inhibitors |
| 08/08/2007 | CN101014593A 1,2,3-triazole derivatives as receptor tyrosine kinase inhibitors |
| 08/08/2007 | CN101014592A Oxazole derivatives as HER tyrosine kinase inhibitors |
| 08/08/2007 | CN101014591A Novel substituted thiophenecarboxamides, their production and their use as medicaments |
| 08/08/2007 | CN101014590A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/08/2007 | CN101014587A Substituted biaryl piperazinyl-pyridine analogues |
| 08/08/2007 | CN101014580A Morpholine compound |
| 08/08/2007 | CN101014574A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 08/08/2007 | CN101014573A 5-HT7 receptor antagonists |
| 08/08/2007 | CN101014572A Carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 08/08/2007 | CN101012223A Ornidazole derivative for treatment, preparing method and use |
| 08/08/2007 | CN101012217A Method of synthesizing landiolol hydrochloride |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253283 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 08/07/2007 | US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 08/07/2007 | US7253192 Phenyl derivatives comprising an acetylene group |
| 08/07/2007 | US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 08/07/2007 | US7253188 Aminobenzamide derivative |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253186 N-substituted piperidine derivatives as serotonin receptor agents |
| 08/07/2007 | US7253185 Amino ceramide-like compounds and therapeutic methods of use |
| 08/07/2007 | US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes |
| 08/07/2007 | US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 08/07/2007 | US7253181 β3 adrenergic agonists |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253170 Pyrazole-amine compounds useful as kinase inhibitors |
| 08/07/2007 | US7253169 Aza compounds, pharmaceutical compositions and methods of use |
| 08/07/2007 | US7253166 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells |
| 08/07/2007 | CA2247734C New piperazine and piperidine compounds selectively binding dopamine and serotonin receptors |
| 08/02/2007 | WO2007087276A1 Aurora kinase modulators and method of use |
| 08/02/2007 | WO2007086799A1 Amide substituted quinolines |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007085540A1 1h-indaz0l-4-yl-2 , 4-pyrimidinediamine derivatives |
| 08/02/2007 | WO2007085451A2 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents |
| 08/02/2007 | WO2007070760A3 Compounds which modulate the cb2 receptor |
| 08/02/2007 | WO2007070606A3 Isoxazolines for controlling invertebrate pests |
| 08/02/2007 | WO2007060408A3 L-phenylalanine derivatives and their use as integrin antagonists |
| 08/02/2007 | WO2007039883A3 Process for preparation of aprepitant |
| 08/02/2007 | WO2007016979A3 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| 08/02/2007 | WO2006112549A8 Fused heterocyclic compound |
| 08/02/2007 | WO2006081391A3 Compounds for inflammation and immune-related uses |
| 08/02/2007 | WO2006073361A9 Novel pyridine compounds |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179191 Oxadiazolones and derivatives thereof as ppar delta agonists |
| 08/02/2007 | US20070179188 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 08/02/2007 | US20070179184 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179141 Therapeutic agents useful for treating pain |
| 08/02/2007 | US20070179140 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity |
| 08/02/2007 | US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 08/02/2007 | US20070179136 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 08/02/2007 | US20070179135 Cannabinoid derivatives |
| 08/02/2007 | US20070179134 Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them |
| 08/02/2007 | US20070179133 Compositions useful as inhibitors of protein kinases |
| 08/02/2007 | US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/02/2007 | US20070179122 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors |
| 08/02/2007 | US20070176541 Organic light emitting compound and organic light emitting device comprising the same |
| 08/02/2007 | CA2640375A1 Pyrimidine derivatives |
| 08/02/2007 | CA2637933A1 Indole sulfonamide modulators of progesterone receptors |
| 08/02/2007 | CA2637081A1 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppressive and anti -inflammatory agents |
| 08/02/2007 | CA2635439A1 Aminophthalazine derivative compounds |
| 08/02/2007 | CA2635124A1 Novel pyridine derivatives |
| 08/01/2007 | EP1813603A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1812429A2 Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 08/01/2007 | EP1812428A2 Zolmitriptan crystal forms |
| 08/01/2007 | EP1812427A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
| 08/01/2007 | EP1812426A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 08/01/2007 | EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 08/01/2007 | EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 08/01/2007 | EP1812400A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| 08/01/2007 | EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 08/01/2007 | EP1812007A2 Pyridazine compounds and methods |
| 08/01/2007 | EP1811993A2 Modulators of crth2, cox-2 and faah |
| 08/01/2007 | EP1811992A2 Methods and compositions using pde4 modulators for treatment and management of central nervous system injury |
| 08/01/2007 | EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 08/01/2007 | EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |